The global influenza virus infection market is anticipated to grow at a considerable CAGR of 5.2% during the forecast period (2022-2028). Increased awareness of the impact of influenza on human health, and the corresponding increase in R&D activities for the launch of novel medications, are two of the key factors for the market growth. Due […]
